What is MosquitoMate?
MosquitoMate operates at the intersection of biotechnology and environmental stewardship, providing a scientifically validated, eco-friendly alternative to traditional chemical-based mosquito control. The company's EPA-registered, non-GMO solutions represent a paradigm shift in how residential and commercial clients manage vector-borne nuisance pests. By focusing on biological population suppression rather than broad-spectrum toxicity, MosquitoMate has carved out a defensible niche in the growing green-tech landscape. Their service model is designed to meet the increasing consumer demand for safe, sustainable outdoor living solutions, effectively replacing conventional sprays with targeted, science-backed interventions that prioritize ecological health alongside human comfort.
How much funding has MosquitoMate raised?
MosquitoMate has raised a total of $331K across 2 funding rounds:
Debt
$150K
Debt
$181K
Debt (2020): $150K with participation from PPP
Debt (2021): $181K led by PPP
Key Investors in MosquitoMate
PPP
Public-Private Partnership
What's next for MosquitoMate?
With the recent influx of capital, MosquitoMate is well-positioned to accelerate its market penetration and refine its service delivery infrastructure. The strategic focus will likely shift toward scaling operational capacity to meet heightened demand for non-toxic pest control solutions. As the company matures, the integration of advanced data analytics to optimize population suppression efforts will be critical for maintaining its competitive edge. Furthermore, the firm is expected to explore broader geographic expansion, leveraging its proven efficacy to capture a larger share of the residential and municipal pest management markets. This phase of growth will be defined by the company's ability to maintain its rigorous scientific standards while achieving the economies of scale necessary for sustained profitability in the late-stage lifecycle.
See full MosquitoMate company page
